Moderna Inches Nearer to Successful Cancer Vaccine

thedailyupside.com Moderna may just have another shot at glory. On Tuesday, the ascendant biopharma player announced positive results in an early-stage trial of the individualized cancer…

Investor Alert: Prepare for the Market Crash With These 3 Stocks

investorplace.com As an investor with significant positions in equities, I am an optimist. However, it’s important to be realistic at the same time. This helps in readjusting the portfolio…

3 Underappreciated Pharmaceutical Stocks to Buy Before They Surge

investorplace.com Pharmaceutical companies with a deep pipeline of new molecular candiadates that will driven growth Big money tends to flow from one sector to the other. During the pandemic,…

Exploring Analyst Estimates for Merck Q1 Earnings, Beyond Revenue and EPS

benzinga.com Wall Street analysts forecast that Merck MRK will report quarterly earnings of $2.01 per share in its upcoming release, pointing to a year-over-year increase of 43.6%. It is…

Martin Wygod, a Winner on Wall Street and the Racetrack, Dies at 84

nytimes.com Martin J. Wygod, a Wall Street whiz who graduated from walking horses after races to owning and breeding championship thoroughbreds when he made millions from investing in…

This High-Yield Vanguard ETF Could Turn $400 per Month Into $18,900 in Annual Dividend Income

finance.yahoo.com Purchasing stocks that consistently pay an above-average dividend can add an element of safety to a portfolio. When I say above average, I mean payouts exceeding the average…

Cramer’s week ahead: Earnings from Tesla, Merck and Big Tech

cnbc.com CNBC's Jim Cramer on Friday noted that major quarterly results from players like Verizon , Meta , Microsoft and Alphabet will be coming next week, but he zeroed in on the…

Langdock raises $3M with General Catalyst to help companies avoid vendor lock-in with LLMs

techcrunch.com Plenty of large corporations want to join the AI revolution, but many feel it’s too early to be locked into one foundational model. That means there’s a market for a layer…

Millions of Girls in Africa Will Miss HPV Shots After Merck Production Problem

nytimes.com Nearly 1.5 million teenage girls in some of the world’s poorest countries will miss the chance to be protected from cervical cancer because the drugmaker Merck has said it…

Got $5,000? Here Are 3 Undervalued Stocks to Buy and Hold Forever

finance.yahoo.com The overall market shows clear indications that it's priced at relatively rich levels right now. But smart investors willing to do a little digging will find that there are…

Coming FDA Approvals Could Send These 3 Drug Stocks Soaring

investorplace.com Find out which drug stocks could skyrocket if the FDA approves their treatments In the biotech and pharmaceutical world, FDA approval is the number one needle mover for drug…

3 Dow Stocks to Buy Now: Q2 Edition

investorplace.com Let’s be real – the narrative for Dow stocks to buy now tends to be one of relative safety. What are the chances that the 30 companies of the Dow Jones Industrial Average…

Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff

benzinga.com On Tuesday, Johnson & Johnson JNJ delivered a rather mixed first quarter report. Adjusted earnings surpassed estimates as sales in its medical devices business surged, while…

1 Simple Vanguard ETF Could Turn $500 Per Month Into $50,000 in Annual Dividend Income

finance.yahoo.com Replacing your paycheck, or at least part of it, with a steady stream of dividends is a great retirement strategy. Not only could you earn enough from your investments to…

If You Like This High-Yield Vanguard Fund, Then You'll Love These Two Dividend Stocks

finance.yahoo.com Whether you are an experienced investor or just getting started, exchange-traded funds (ETFs) can be a great addition to your portfolio for their diversification and…

7 ‘A-Rated’ Aggressive Biotech Stocks to Bet On in 2024

investorplace.com If you have patience, biotech stocks can be big winners The best biotech stocks to buy are in companies that put a lot of resources into research and development, often with…

How Ivermectin Trials Were Designed To Fail

zerohedge.com How Ivermectin Trials Were Designed To Fail Authored by Yuhong Dong via The Epoch Times (emphasis ours), The use of ivermectin to treat COVID-19 is an ongoing debate. The…

Stu Sjouwerman, Founder and CEO of KnowBe4, Presented with Holland on the Hill Freddy Heineken Award

benzinga.com Washington, D.C., April 11, 2024 (GLOBE NEWSWIRE) -- The Embassy of the Kingdom of the Netherlands, the U.S. Congressional Caucus on the Kingdom of the Netherlands, and the…

Up 6% on Upbeat Data From Cancer Jab Study

benzinga.com Shares of Moderna MRNA rose 6.2% on Apr 9 after management announced encouraging data from a portion of an early-stage study on mRNA-4157/V940, its investigational…

Vaccine Player Vaxcyte Has Advantage Over Pfizer, Merck's Pneumococcal Shots - Analyst Says

benzinga.com The global market study pneumococcal conjugate (PCV) market is ~$8 billion per year, and Vaxcyte Inc PCVX estimates it will grow to ~$12 billion in the next few years. The…